FDA Approves Celgene’s Otezla for PsA
The federal Food and Drug Administration has given its nod to Otezla (apremilast) for the treatment of adults with active psoriatic arthritis (PsA).
The federal Food and Drug Administration has given its nod to Otezla (apremilast) for the treatment of adults with active psoriatic arthritis (PsA).
Anil Shah, MD, FACS, a Chicago-based facial plastic surgeon, shares insights on the evolution of hair restoration, emerging treatments, and advice for patients.